Mediterranean diet improves nutritional status
- Trial ID
- NCT07187739
- Official Title
- Investigation of the Effect of the Mediterranean Diet on Nutritional Status in Parkinson's Patients Undergoing Bilateral Subthalamic Nucleus Deep Brain Stimulation
- Goal
- Mediterranean diet improves nutritional status
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Ankara University
- Study Type
- INTERVENTIONAL
- Enrollment
- 24 participants
- Conditions
- Parkinson Disease, Deep Brain Stimulation, Deep Brain Stimulation Surgery
- Interventions
- Mediterranean diet
Plain-Language Summary
They want to see if following a Mediterranean diet can improve nutritional status for people with Parkinson's who are having bilateral subthalamic nucleus deep brain stimulation, a time when weight and nutrition often change. The plan is a Mediterranean eating pattern high in fruits, vegetables, whole grains, olive oil, fish and nuts to boost calories, protein, vitamins and anti-inflammatory antioxidants, which may help maintain weight and recovery; the diet itself does not change antiparkinsonian drugs, though timing of protein can affect levodopa absorption and will be managed while patients continue their meds. The trial is looking for men and women aged 45 to 64 who are scheduled for STN DBS, stay on their Parkinson's medications, have a Mini Mental Test score of 24 or higher, and do not have psychiatric illness or another condition needing a special diet.
Locations
- Ankara Etlik City Hospital, Ankara, Ankara, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Mediterranean diet. They want to see if following a Mediterranean diet can improve nutritional status for people with Parkinson's who are having bilateral subthalamic nucleus deep brain stimulation, a time when weight and nutrition often change. The plan is a Mediterranean eating pattern high in fruits, vegetables, whole grains, olive oil, fish and nuts to boost calories, protein, vitamins and anti-inflammatory antioxidants, which may help maintain weight and recovery; the diet itself does not change antiparkinsonian drugs, though timing of protein can affect levodopa absorption and will be managed while patients continue their meds. The trial is looking for men and women aged 45 to 64 who are scheduled for STN DBS, stay on their Parkinson's medications, have a Mini Mental Test score of 24 or higher, and do not have psychiatric illness or another condition needing a special diet.
- Who can participate?
- Participants must be between 45 Years and 64 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 5 months.